Skip to main content
Journal of the West African College of Surgeons logoLink to Journal of the West African College of Surgeons
. 2011 Apr-Jun;1(2):63–75.

THE CHALLENGES OF TREATING LARYNGEAL CARCINOMA IN JOS, NIGERIA

AS ADOGA 1,, EN MA’AN 1
PMCID: PMC4170258  PMID: 25452954

Abstract

Background

Laryngeal cancers are not uncommon with several factors affecting its management in our environment compared to the developed countries. Such factors include the time of presentation and diagnosis, co-morbid disease, finance, consent, treatment options, surgical expertise and the problems of follow up. Thus this results to a lot management challenges to both the patients and the care givers.

Aim

The aim of this paper is to highlight the challenges encountered in the management of laryngeal cancers at the Jos University Teaching Hospital, Nigeria.

Design of study

it is a retrospective study.

Setting

The study was carried out at the ENT department of the Jos University Teaching Hospital and Bingham (ECWA Evangel) Hospital Jos Nigeria.

Method

This was a 48-month (October 2005 – September 2009) review of laryngeal cancers seen and treated in these hospitals. Data extracted included age, gender, histologic diagnosis and treatment modality. Data was analyzed using simple descriptive method and the result presented in tabular forms.

Result

A total of twenty one (21) cases consisting of 20 males and a female were seen during the period. The age range was 30 years to 70 years. The average age was 56.14 years. The time of presentation ranged from 3 months (earliest) to 2years. Twenty cases (95.24%) were advanced diseases with only one early disease.

The histological types were 6 each for well and moderately differentiated squamus cell carcinoma respectively, 2 each for poorly differentiated and squamus cell carcinoma (uncharacterized) and 1 carcinoma insitu.

Two patients (a male and female) were seropositive for HIV type I.

Twenty (95.24%) of the patients had tracheostomy at presentation with two having peristomal spread in the course of the disease.

Eight (38.10%) patients had total laryngectomy out of which one was a salvage laryngectomy with subsequent right pectoralis major myocutaneous flap; 6 had concomitant chemoradiotherapy with one discontinuing after the first course and while the sixth total laryngectomee had no chemoradiotherapy.

Three (14.29%) had primary radiotherapy; 2 of the cases were advanced diseases and one early disease. Eight (38.10%) had no treatment.

Of the 6 laryngectomees, three had tracheo-oesophageal fistula post-operatively while one had disease recurrence and died.

The first laryngectomy case is still on follow-up, disease free four years now while the rest have been lost to follow up.

Conclusion:

Education and provision of standard oncologic treatment centres with trained personnel will help in alleviating theses challenges by providing treatment, data for assessment and improving the standard of our treatment.

Keywords: Challenges in management, Laryngeal carcinoma, Jos, Nigeria

Introduction

Laryngeal cancers amongst which the squamous cell carcinoma is the most common in the developed world are not uncommon in our environment1,2. However considerable variations exist in the incidence of this disease between various countries. Several factors appear to affect the management of this disease in our environment compared to other countries. Such factors include the time of presentation, diagnosis, co-morbid states, availability of finance, consent, treatment options and the problems of follow-up. 3,4

The management of laryngeal carcinoma therefore poses a lot of challenges to both the patients and the managing team.

Aim: It is thus the aim of this study to highlight the challenges noted in the management of this disease and suggest possible ways of improving the trend.

Design of study: it is a retrospective study.

Setting: Thestudy was carried out at the ENT department of the Jos University Teaching Hospital and Bingham (ECWA Evangel) Hospital Jos Nigeria.

Method:

The City of Jos is located within the North Central geopolitical zone ofNigeria. It has a population of five hundred and ten (510,000) people. This study was undertaken at two tertiary health facilities in Jos. Apart from Jos inhabitants, these two centers serve patients from a catchment area of over 280 kilometer radius. Only six out of about 135 Otolaryngologists in Nigeria are practicing in Jos. There is no speech pathologist/therapist presently practicing here.

Inclusion criteria:All laryngeal cancer patients who presented within the study period.

Exclusion criteria: Benign laryngeal diseases.

This is a 48-month (October 2005 – September 2009) retrospective review of twenty onelaryngeal cancers at the Jos University Teaching Hospital and Bingham (ECWA Evangel) Hospital Jos.

Data extracted included age, gender, duration before presentation, histological subtypes and treatment modality. The data collected were analyzed using simple descriptive method and results presented in tabular forms.

Results

A total of twenty one (21) cases consisting of 20 males and 1 female were seen during the period. The patients’ ages ranged from 30 to 70 years. The youngest patient was 30 years and the oldest was 70 years. The average age was 56.14 years. The duration of symptoms before presentation ranged from 3 months (earliest) to 2years. Twenty (95.24%) cases were advanced diseases while 1 was an early disease.20(95.24%) of the patients were T4s with various nodal and metastatic status. That is; 9(37.50%) were T4NXMX, whereas9(37.50%) wereT4N1MX while 1(4.76%) each was T1aN0Mx, T4N1M1 and T4N1M1 respectively.

All the 21(100%) patients presented with hoarseness, 20 (95.24%) had stridor and upper airway obstruction while only 2(9.52%) came in with neck pain and swelling. 15(71.43%) smoked, 16(76.19%) drank alcohol, 14(66.67%) were local farmers, 10(47.61%) had western education against 16(76.19%) who had no formal education while only 3(14.29%) were unmarried.

The earliest presentation was 3 months while the longest was 2 years.

The histological types were 8 each for well and moderately differentiated squamous cell carcinoma respectively, 2 each for poorly differentiated and squamous cell carcinoma (uncharacterized) and 1 carcinoma insitu.

Two patients (a male and female) were seropositive for HIV type 1.

Twenty (95.24%) of the patients had tracheostomy at presentation; with two having peristomal spread in the course of the disease.

Eight (38.10%) patients had total laryngectomy out of which one was a salvage laryngectomy with subsequent right pectoralis major myocutaneous flap; 5 had concomitant chemoradiotherapy with one discontinuing after the first course and while the sixth total laryngectomee had no chemoradiotherapy.

Three (17.65%) had primary radiotherapy; 2 of the cases were advanced diseases and one early disease. Eight (38.10%) had no treatment because of poor social economic back ground, illiteracy and refusal of consent.

Of the 6 laryngectomees, three had tracheo-oesophageal fistula post-operatively while one had disease recurrence and died.

The first laryngectomy case is still on follow-up, disease free four years now while the rest have been lost to follow up.

Table 1. Showing the age, sex, time of presentation, histological types and treatment options for the patients with laryngeal carcinomas

S/no. Age (yrs) TOP Sex Histological type Treatment Outcome
1 45 6M M wdscc TL, RTH, CT (alive)
2 43 8M M wdscc metastasis (dead)
3 60 12M M scc no treatment (unknown)
4 69 9M M cai no treatment (unknown)
5 65 13M M mdscc no treatment (unknown)
6 66 13M M mdscc RT (alive)
7 65 15M M wdscc TL, RTH, CT (alive)
8 65 17M M scc TL, RTH, CT (alive)
9 70 24M M wdscc RT, CT, STL, (died, TOF)
10 45 15M M wdscc no treatment (dead)
11 70 18M M wdscc no treatment (unknown)
12 65 12M M pdscc TL (alive)
13 30 13M M mdscc no treatment (alive)*
14 32 7M M pdscc no treatment (dead)*
15 44 3M M mdscc RTH (alive)
16 65 18M M mdscc TL, CT, RT (alive)
17 60 9M M mdscc no treatment (unknown)
18 70 12M M wdscc TL (dead)
19 45 12M M wdscc TL, RTH (alive)
20 55 8M M mdscc CT (alive)
21 50 6M M mdscc CT (alive)

ABBREVIATIONS

TL- total laryngectomy

STL-salvage total laryngectomy

RTH-radiotherapy

CT- chemotherapy

Wdscc- well differentiated squamus cell carcinoma

Scc- squamus cell carcinoma

Cai- carcinoma insitu

Mdscc- moderately differentiated squamus cell carcinoma

Pdscc- poorly differentiated squamus cell carcinoma.

TOF- Tracheo-Oesophageal fistula.

* HIV positive

TOP- time of presentation in months.

Conclusions

Government intervention to subsidize the high cost of investigations and treatment of these patients and public health enlightmentprogramme are a must for improved results to be obtained.

In addition the provision of standard oncologic treatment centres with trained personnel will help in alleviating theses challenges by providing treatment, data for assessment and improving the standard of treatment of these patients in our environment.

Discussion

The main findings were most of the patients were in the sixth to seventh decade(57.14%),advanced presentation (95.24%),lack of formal education (76.19%),lack of finance (38.10%),alcohol consumption(76.19%),smoking(71.43%) and chemoradiotherapy outside managing hospital(100%), delayed referral by physicians (14.29%) .

The age range and average age of the population studied were similar to the findings of Adeyemo5 at the University College Ibadan where the mean age and age range were 57.5 years and 28years to 84years respectively but in contrast to a previous study from same environment in Jos, Nigeria by Lilly-Tariah6 whose study population had a mean age of 47.7 years. Laryngeal cancers occur predominantly in the male gender all over the world as was also noted in this study.5,6,7,8,9. Significant differences exist in how laryngeal cancers affect the male and female gender and this has been speculated to be due to the different susceptibilities of the cancer cells to steroid hormones. The duration of symptoms before presentation ranged from 3 months to 2years. The advantage of early presentation is that of cure with less invasive therapeutic measures.10,11,12. All but one of the patients in this present study presented with advanced disease.13

The histological types were mainly squamous cell carcinoma with various grades of differentiation. Jaiswaland co workers14 also had similar findings with 99% of primary laryngeal carcinomas being squamous cell in type.

Since the emergence of retroviral disease, there has been an increase in the number of head and neck cancers, laryngeal cancers inclusive in HIV seropositive patients in our country and the world over.4,15,16 thus the findings in this study may be a reflection of this. One out of the ten HIV seropositive patients in Nwaorgu and co-workers study had laryngeal carcinoma.15 The two HIV seropositive cases in this study who were in the fourth decade of life had histologically poorly differentiated Squamous Cell carcinoma.

The clinical features were that of persistent hoarseness, followed by upper airway obstruction. All the 21(100%) patients presented with hoarseness, 20 (95.24%) had stridor and upper airway obstruction while only 2(9.52%) came in with neck pain and swelling.

Most of the patients had history of smoking and alcohol consumption.5,6,17

19(90.48%) smoked, 18(85.71%) drank alcohol, 16(71.43%) were local farmers, 9(42.86%) had western education against 16(76.19%) who had no formal education while only 3(14.29%) were unmarriedSometimes they were delayed referral as three (14.29%) cases were treated for Asthma and tuberculosis before referral. Similar medical cause of delay was noted by Teliet al.5,18

The high rate of tracheostomy in this study (95.24%) calls for concern. This apparently resulted from the need to relieve the obstructed upper airway on late presentation by the patients. It was thus easy obtaining consent for the procedure in contrast to the difficulty faced while seeking consent for total laryngectomy especially with the information on voice loss and dysphagia.19,20 It is however worthy of note that relief of upper airway obstruction was the commonest indication for tracheostomy in our centre while elsewhere steroid has been used in combination with radiotherapy.21, 22 The only non tracheostomized patient in this study presented early; was commenced on steroid intra-operatively during direct laryngoscopy and biopsy. In our environment sadly some of the tracheostomized patients decline from further treatment as soon as they are relieved of their obstruction. Some of the demerits of the presence of tracheostomy tube are the promotion of infections and fibrosis leading to difficult and prolonged operation time.

It is argued that tracheostomy aids peristomal spread,a feature which was also noted in this study.23, 24

Treatment depends on TNM stage as shown in table 2 below. Total laryngectomy followed by concomitant radio-chemotherapy was the major treatment modality as noted in this study with a better outcome. Other workers like Nishant25 et al had similar result as against the findings of Marcy et al26 and Anupam et al27 in other parts of the word.

Three (14.28%) had primary radiotherapy, 2 (9.52%) of the cases were advanced diseases and one (4.76%) early disease. Eight (38.10%) had no treatment.

The two advanced cases had residual disease meaning that radiotherapy for advanced laryngeal disease is not the best treatment option in our environment as against the good outcome in other countries by James, Arlene and coworkers. 28,29 Radiotherapy leads to difficult dissection, prolonged operation time; poor wound healing and increased post operative complications.30

From the fore going it is a sad fact a great majority of our patients present late with advanced laryngeal cancer. Poor knowledge of the disease, poverty (38.10% of patients in this study could not afford the cost of any form of treatment), lack of specialists in the field and poor referral system contribute to late presentation. In addition to these, appropriate and effective diagnostic (endoscopic tools, CT- scans, MRI) and treatment facilities (Chemo-radiation centers, experienced personnel) are few or lacking leading to poor outcome.

The few Radiotherapy centers have a deluge of patients on queue for treatment and thus over stretched. Our center does not have a radiotherapy facility. The closest tertiary institution with this facility where our patients are usually referred to is about 380 Kilometers. Thus attendance and compliance at this facility by the patients most likely will be far from satisfactory. There is the possibility that four of the total laryngectomy patients who were lost to follow- up as soon as they were referred may be in this category.

It is on note also that poverty of knowledge of the disease both on the part of the patient and the first contact physician contributed to the dismal outcome of the treatment in these patients, a feature also noted by some other workers.5,31

Primary haemorhage and tracheo-oesophageal fistula were the commonest complications noted in this study which have also been cited by other workers.32,33, 34

The first case is on follow up and disease free for four years now.35 The rest were lost to follow up for various reasons.

Table 2: The TNM staging of the 21 patients

Serial number Tumour (T) Nodes (N) Metastasis (M) Summary
1 4 1 X T4N1MX
2 4 2a 1(chest/ribs/lungs) T4N2aM1
3 4 X X T4NXMX
4 4 X X T4NXMX
5 4 X X T4NXMX
6 4 X X T4NXMX
7 4 1 X T4N1MX
8 4 1 X T4N1MX
9 4 1 X T4N1MX
10 4 X X T4NXMX
11 4 X X T4NXMX
12 4 X X T4NXMX
13 4 1 1(thyroid) T4N1M1
14 4 X X T4NXMX
15 1a No X T1aN0Mx
16 4 1 X T4N1MX
17 4 X X T4NXMX
18 4 1 X T4N1MX
19 4 1 X T4N1MX
20 4 1 X T4N1MX
21 4 1 X T4N1MX

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Grant support: None

References

  • 1.Adoga AS, John EN, Yiltok SJ, Echejoh GO, Nwaorgu O.G. The Pattern of head and neck malignant tumours in Jos. The Highland Medical Research Journal. 2009;8(1):37–41. [Google Scholar]
  • 2.Martin M, Harisha K, Faiza M, Robert A, Babak B, Jongdae S, Vasken D. J Nucl Med. 1. Vol. 49. 2008: The role of PET/CT in the management of laryngeal cancer; pp. 179–179. [Google Scholar]
  • 3.Maran AGD, Stell PM. In: Treatment options: the Principles of surgery. Vol. 4. Linacre House, Oxford: Butterwort-Heinemann; 2000. Stells and Maran`s Head and Neck Surgery; pp. 49–81. [Google Scholar]
  • 4.Blenke E, Clement W, Andrews J, Scanlon E, Vernham G. Squamus cell carcinoma in HIV-Positive patients: Difficulties in diagnosis and management. Dysphagia. 2007;22(1):68–72. doi: 10.1007/s00455-006-9034-7. [DOI] [PubMed] [Google Scholar]
  • 5.Adeyemo AA, Mohammed GM. Laryngeal carcinoma in Sub Saharan Africa. J Clin Oncol . 2008;26:17022–17022. [Google Scholar]
  • 6.Lilly-Tariah OB, Ukoli CO, Nwanna EJ. Cancer of the larynx in black Africans in Jos Nigeria. The central African Journal of Medicine. 1999;45(2):40–42. doi: 10.4314/cajm.v45i2.8450. [DOI] [PubMed] [Google Scholar]
  • 7.Ogunbiyi O, Nwaorgu G. Aetiological correlates in Nigerian laryngeal cancers. Virchows Archiv. 2003;443:259–259. [Google Scholar]
  • 8.Opubo B, Lilly-Tariah DA, Somefun AO, Adeyemo W. [Google Scholar]
  • 9.Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California and Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys. 2001;50(5):1178–80. doi: 10.1016/s0360-3016(01)01538-3. [DOI] [PubMed] [Google Scholar]
  • 10.Nishant Agrawal, Management of Early-Stage Laryngeal Cancer. Otolaryngologic clinics of North America41. 2008;41(4):757–769. doi: 10.1016/j.otc.2008.01.014. [DOI] [PubMed] [Google Scholar]
  • 11.Sankaranarayanan R, Agnihotram V, Ramanakumar V, Balakrishna B. Yeole. Survival from glottic and supraglottic laryngeal carcinoma in Mumbai (Bombay), India. Oncology. 2003;Oncology:656–663. doi: 10.1016/s1368-8375(03)00052-6. [DOI] [PubMed] [Google Scholar]
  • 12.Hoare TJ, Thompson HG, Proops DW. Detection of laryngeal cancer-the case for early specialist assessment. R Soc Med . 1993;86(390):392. doi: 10.1177/014107689308600707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Otoh EC, Johnson NW, Mandong BM, Danfillo IS. Primary head and neck cancers in Jos: a re-visit. West Afr J Med. 2006;25(2):92–100. doi: 10.4314/wajm.v25i2.28256. [DOI] [PubMed] [Google Scholar]
  • 14.Jaiswal VR, Hoang MP. Primary combined squamus and small cell carcinoma of the larynx: A case report and review of literature. Arch Pathol Lab Med. 2004;128(11):1279–82. doi: 10.5858/2004-128-1279-PCSASC. [DOI] [PubMed] [Google Scholar]
  • 15.Nwaorgu O, Kokong D, Onakoya P, Adoga S, Ibekwe T. Prevalence of Human Immunodeficiency Virus seropositivity in Head and Neck Malignancies in Sub-Saharan Africa. Acta Otolaryngol. 2007;127(11):1218–1221. doi: 10.1080/00016480701230936. [DOI] [PubMed] [Google Scholar]
  • 16.Akinwande O, Ogundiran T, Akorolo-Anthony S, Mamadu I, Dakum P, Blattner W, Adebamowo C. Challenges in treating malignancies in HIV in Nigeria. Current Opinion in Oncology. 209;21(5):455–461. doi: 10.1097/CCO.0b013e32832e6385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nwaorgu OGB, Onakoya PA, Usman MA, Abdu A. Laryngeal carcinoma: Clinical features seen at University College Hospital, Ibadan. Tropical Doctor . 32;32:236–237. doi: 10.1177/004947550203200420. [DOI] [PubMed] [Google Scholar]
  • 18.Teli MA, Kuchay SU, Kharadi MY, Lone MM. Late presentation in cancer: who is responsible? JK Practitioner. 195;4(2):165–168. [Google Scholar]
  • 19.Eugene A, Young J Kim. Laryngeal Cancer: Diagnosis and Preoperative Work-up. Otolaryngologic clinics of North America. 2008;41(4):673–695. doi: 10.1016/j.otc.2008.01.016. [DOI] [PubMed] [Google Scholar]
  • 20.Maran AGD, Stell PM, Stells Maran, Watkinson JC, Gaze MN, Wilson JC. Butterwort-Heinemann, Linacre House Oxford. Head and Neck Surgery. In: Tumours of the larynx. 2000;4:233–274. [Google Scholar]
  • 21.Adoga AS, Otene AT, Unuajohwofia O, Nwaorgu OGB. Upper Airway Obstruction Requiring Tracheostomy in Jos, Nigeria. Journal of Medicine in the Tropics. 2007;9(2):41–45. [Google Scholar]
  • 22.Howard Hessan, John Houck, Harold Harvey. Airway obstruction due to lymphoma of the larynx and trachea. The Laryngoscope. 2009;;98(2):176–180. doi: 10.1288/00005537-198802000-00011. [DOI] [PubMed] [Google Scholar]
  • 23.Halfpenny W, MCgurck Mark. Stomal recurrence following temporary tracheostomy. J laryngol Otol. 2001;115(3):202–204. doi: 10.1258/0022215011907190. [DOI] [PubMed] [Google Scholar]
  • 24.Fagan JJ, Loock JW. Tracheostomy and peristomal recurrence. Clin Otolaryngol. 1996;21:328–330. doi: 10.1111/j.1365-2273.1996.tb01080.x. [DOI] [PubMed] [Google Scholar]
  • 25.Nishant Agrawal, Patrick K. Management of Early-Stage Laryngeal Cancer. Otolaryngologic clinics of North America. 2008;41(4):757–769. doi: 10.1016/j.otc.2008.01.014. [DOI] [PubMed] [Google Scholar]
  • 26.Marcy A, List Amy,, Daniel Haraf, Phil Schumm, Merrill Kies. Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination. J Clin Oncol. 1999;17(3):1020. doi: 10.1200/JCO.1999.17.3.1020. [DOI] [PubMed] [Google Scholar]
  • 27.Anupam Kumar Asthana, Rajeev Kumar Jain, Girish Chandra Pant, Om Prakash Singh. Sequential methotrexate and Radiotherapy in advanced laryngeal cancer. Indian Journal of Otolaryngol. Head and Neck Surgery. 1989;41(3):127–130. [Google Scholar]
  • 28.James T, Parsons William M, Mendenhall Scott P, Stringer Nicholas, J Cassisi. T4 laryngeal carcinoma: Radiotherapy alone with surgery reserved for salvage. Int Journal of Radiation Oncology, Biology, Physics. 1998;40(3):549–552. doi: 10.1016/s0360-3016(97)00850-x. [DOI] [PubMed] [Google Scholar]
  • 29.Arlene A, Forastiere Helmuth Goepfert, Moshe Maor, Thomas F Pajak, Randal Weber, William Morrison, Bonnie Glisson, Andy Trotti, John A, Ridge Clifford,, Glen Peters, Ding-Jen Lee, Andrea Leaf, John Ensley, Jay Cooper. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer. NEJM. 2003;349(22):2091–2098. doi: 10.1056/NEJMoa031317. [DOI] [PubMed] [Google Scholar]
  • 30.Croll GA, Gerritsen GJ, Tiwari RM, Snow GB. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications. Strahlentther onkol. 1992;168(1):1–16. [PubMed] [Google Scholar]
  • 31.Hoffman HT, Karnel LH, Funk GF, Robinson RA, Menck HR. Arch Otolaryngol. Neck Surg. 1998;124:951–962. doi: 10.1001/archotol.124.9.951. [DOI] [PubMed] [Google Scholar]
  • 32.Andrea L, Cavalot C, Fernando Gervasio, Giuseppe Nazionale, Roberto Albera, Mario Bussi, Alberto Staffieri, V Ferrero, G Cortesina, cutaneous Pharyngo. fistula as a complication of total laryngectomy: Review of the literature and analysis. Head and Neck Surgery. 2000;123(5):587–592. doi: 10.1067/mhn.2000.110617. [DOI] [PubMed] [Google Scholar]
  • 33.Jesús Herranz, Adolfo Sarandeses, Mario Fernández Fernández, Carlos Vázquez Barro, José Martínez Vidal, Javier Gavilán. Complications after total laryngectomy in nonradiated laryngeal and hypopharyngeal carcinoma. Otolaryngol. Head and Neck Surgery. 2000;122(6):892–898. doi: 10.1016/S0194-59980070020-9. [DOI] [PubMed] [Google Scholar]
  • 34.Jones SJ, Hedley AJ, Young RE, Dinwoodie DL, Bewsher PD. Lost to follow up': reasons for continued surveillance in a follow-up register. Journal of Public health. 1981;3(1):25–30. [PubMed] [Google Scholar]
  • 35.Brown S, Belgaumi A, Ajarim D, Kofide A, AlSaad R, Sabbah R, Ezzat A, Shoukri M, Levin A. Lost to follow-up of patients with malignant lymphoma. European Journal of Cancer care. 2004;13(2):180–184. doi: 10.1111/j.1365-2354.2004.00461.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the West African College of Surgeons are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES